Next, we further inspected if this trend could be different in BC cell lines considered as a model system for LumA (i.e., ERα-positive; PR-positive/negative and HER2-negative) or LumB (i.e., ERα-positive; PR-positive/negative and HER2-positive) BC [14,15]. The gene discussed is ERBB2; the disease is breast cancer.